Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma

<p><b>Background</b></p> Mepolizumab is an anti-interleukin-5 monoclonal antibody treatment for severe eosinophilic asthma (SEA) that reduces asthma exacerbations. Residual airway inflammation on mepolizumab may lead to persistent exacerbations. Oral corticosteroids remain th...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Howell, I, Yang, F, Brown, V, Cane, J, Marchi, E, Azim, A, Busby, J, McDowell, PJ, Diver, SE, Borg, C, Heaney, LG, Pavord, ID, Brightling, CE, Chaudhuri, R, Hinks, TSC
التنسيق: Journal article
اللغة:English
منشور في: Elsevier 2024